MK (@MK_TRADES) | Stocktwits

$ATNF thelancet.com/journals/ebio...

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

via: EBioMedicine

3

3

Drunkcowsmoonow

@MK_TRADES So just read through it and still confused...

@Drunkcowsmoo Go through it slowly, a lot of good things indicated here.